Delivery Order SPE2DB20D1004-SPE2DB25FNFUD
Award Date
3/21/25
Potential Completion Date
3/24/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,888.95, is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a completion date of February 26, 2025. The contract is not designated as a set-aside and was open to full and open competition....
This is a delivery order under a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of XHANCE 93 MCG nasal spray, a prescription medication. The delivery order has a ceiling value of $2,801.61 and is for a firm fixed price. It is scheduled for completion by August 22, 2024. The contract does not have a set-aside designation. As a notable supplier to the federal government,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XHANCE 93 MCG Nasal Spray, a pharmaceutical product, with a ceiling value of $1,212.30 and a completion date of February 4, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,467.65, is for the delivery of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product. The contract is a Firm Fixed Price, Delivery Order contract with a completion date of June 25, 2024. The contract was not set aside for any specific business category. AmerisourceBergen Drug Corp...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,503.74 firm fixed-price contract is for the supply of Xhance 93 MCG Nasal Spray 16ML, with a period of performance through December 5, 2024. This award is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,436.26, is for the delivery of XHANCE 93 MCG Nasal Spray 16ML, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a completion date of December 18, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of medical products including the medication XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,144.68 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the pharmaceutical product XHANCE 93 MCG NASAL SPRAY 16ML. The contract has a ceiling value of $1,026.39 and a period of performance through April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA that serves as the primary vehicle for the company to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,161.81 firm fixed-price delivery order is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a specialty pharmaceutical product. The contract has an ultimate completion date of December 18, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. The contract is for the supply of XHANCE 93 MCG NASAL SPRAY 16ML, a pharmaceutical product, under a Firm Fixed Price delivery order. The contract has a ceiling value of $1,690.88 and a completion date of December 18, 2023. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...